Albemarle Q3 Net Income Hits $297M as Lithium Prices Surge 95%

Albemarle Corporation (NYSE: ALB) reported third-quarter 2026 net sales of $1.55 billion on November 4, 2026, up 18.8% from $1.31 billion a year earlier, as the company announced its results for the quarter ended September 30, 2026. Net income attributable to Albemarle reached $296.8 million, or $2.15 per diluted share, reversing a $160.7 million loss in the prior-year quarter. Adjusted EBITDA climbed 186.1% to $645.5 million, which the company attributed to higher lithium pricing and cost improvements.

Context — Why Albemarle's Q3 2026 Earnings Matter Now

The company's own year-over-year comparison is the sharpest lens on this quarter. A year ago Albemarle posted a net loss of $160.7 million and adjusted diluted loss per share of $0.19. The swing to $2.58 in adjusted diluted earnings per share reflects how quickly lithium pricing has moved through the income statement.

Energy Storage realized prices averaged $20.02 per kilogram of lithium carbonate equivalent in Q3 2026, against $10.28 a year earlier — a 94.7% increase. That pricing shift, not volume, drove the segment's $410 million net sales gain. Sales volumes actually fell 18.8% to 56 kT LCE, which the company attributed to timing events in the prior-year period, including inventory destocking and unusually high spodumene shipments that made Q3 2025 its record volume quarter.

The macro backdrop matters because Albemarle's results are a read-through on lithium contract repricing across the battery supply chain. The company said global lithium demand rose 48% year-to-date through August, driven by electric vehicles and energy storage. That demand figure, paired with the price move, is the catalyst chain investors are tracking: demand growth is now flowing into realized pricing rather than being absorbed by inventory.

The cost side reinforced the operating use. Albemarle said it delivered more than $150 million in year-to-date run-rate cost and productivity improvements, hitting the high end of its full-year target. Higher pricing and a lower cost base moved together in the same quarter.

Data — What Albemarle's Q3 2026 Numbers Show

The headline figures span three segments and the corporate line. Total net sales rose 18.8% to $1.55 billion. Adjusted EBITDA of $645.5 million compares with $225.6 million a year earlier. Operating cash flow was $406 million for the quarter, with free cash flow of $325 million and operating cash flow conversion of 63%.

Metric	Q3 2026	Q3 2025	Change
Net sales	$1,553.1M	$1,307.8M	+18.8%
Net income (loss) attributable to ALB	$296.8M	$(160.7)M	NM
Adjusted EBITDA	$645.5M	$225.6M	+186.1%
Diluted EPS	$2.15	$(1.72)	NM
Adjusted diluted EPS	$2.58	$(0.19)	NM

Energy Storage net sales reached $1,118.8 million, up 57.9%, with adjusted EBITDA of $559.8 million against $124.1 million — a 351.2% increase. Specialties net sales rose 12.7% to $388.6 million, with adjusted EBITDA up 30.7% to $98.7 million, helped by bromine pricing and volume growth.

On the balance sheet, Albemarle reported estimated liquidity of roughly $3.4 billion as of September 30, 2026, including $1.8 billion in cash and equivalents. Total debt stood at $1.9 billion, giving a net debt to adjusted EBITDA ratio of approximately 0.3. Year-to-date free cash flow reached $1.2 billion, and capital expenditures for the first nine months were $251 million, down $184 million versus the prior-year period.

The company did not disclose the specific contract terms behind its Energy Storage pricing, nor the counterparties to those agreements.

Analysis — What the Lithium Price Recovery Means for Markets

Albemarle's results are a leveraged expression of the lithium price cycle, and the segment data makes the mechanism explicit. Energy Storage adjusted EBITDA of $559.8 million on $1,118.8 million of sales implies a margin near 50%, versus roughly 17.5% a year earlier. That expansion came almost entirely from price, since volumes declined.

The second-order effect runs through the battery materials supply chain. Companies with spodumene exposure and unhedged lithium contracts see earnings move with realized prices, while downstream cell makers and automakers face higher input costs if pricing holds. The report does not name specific peers, so the read-through is directional rather than quantified.

The counter-argument sits in the company's own fourth-quarter guidance. Albemarle said Q4 2026 net sales and adjusted EBITDA are expected to decrease sequentially due to lower market pricing with steady volumes, and that margins will compress as higher-cost spodumene inventory purchased in prior periods flows through cost of goods sold. The Q3 margin may therefore be a local peak rather than a new baseline.

The scenario table sharpens that risk. Under the observed market price case, where lithium averages roughly $10 per kilogram LCE, Albemarle projects full-year 2026 net sales of $4.1-$4.3 billion and adjusted EBITDA of $0.9-$1.0 billion. At a $20 per kilogram average, those figures rise to $5.7-$6.0 billion and $2.4-$2.6 billion. At $30 per kilogram, the company sees $7.5-$7.8 billion in sales and $4.2-$4.4 billion in adjusted EBITDA.

Positioning follows the price path. Investors holding ALB are effectively long a lithium price recovery that the company itself says is not guaranteed into the fourth quarter, while the low net debt ratio of 0.3 gives the balance sheet room to absorb a downcycle.

Outlook — What to Watch Next for Albemarle and Lithium

Albemarle raised its Specialties adjusted EBITDA outlook to $350-$375 million from $275-$325 million, citing cost and productivity improvements. It cut full-year capital expenditure guidance to $300-$350 million from approximately $500 million, reflecting capital efficiency gains and resequencing of early-stage projects.

Sales volumes for the full year are expected in a range of 225 to 235 kilotons LCE. The company said increased Wodgina volumes partially offset a delay in the Talison CGP3 ramp following a fire on June 9, 2026. Talison's Chemical Grade Plant 3 achieved 30 days of nameplate performance in September.

The company scheduled its earnings call for Thursday, November 5, 2026 at 8:00 AM Eastern time. Fourth-quarter margin trajectory, spodumene inventory costs, and any update on CGP3 ramp timing are the specific items that will determine whether the Q3 earnings beat carries into 2027. Investors should also watch the adjusted effective tax rate, which the company guides to a range of negative 50% to 30%, dependent on lithium prices and geographic income mix.

Frequently Asked Questions

What does Albemarle's Q3 2026 earnings beat mean for retail investors?

It signals that lithium pricing has moved from a drag to a driver of earnings. Albemarle's adjusted EBITDA rose 186% year over year to $645.5 million, and adjusted diluted EPS swung to $2.58 from a loss of $0.19. However, the company guides fourth-quarter sales and EBITDA lower sequentially, so the quarter reflects current pricing rather than a locked-in trend.

Why did Albemarle's Energy Storage volumes fall while revenue rose 58%?

The company said the prior-year quarter was its record volume quarter on an LCE basis, boosted by inventory destocking and unusually high spodumene shipments. That makes the year-over-year volume comparison unfavorable. Revenue still rose because realized prices nearly doubled to $20.02 per kilogram LCE from $10.28, overwhelming the volume decline.

What happens to Albemarle if lithium prices fall back to $10 per kilogram?

Under the company's own observed market price case, where lithium averages roughly $10 per kilogram LCE, Albemarle projects full-year 2026 net sales of $4.1-$4.3 billion and adjusted EBITDA of $0.9-$1.0 billion — roughly half the EBITDA implied by the $20 per kilogram scenario. The company's net debt to adjusted EBITDA ratio of 0.3 provides balance sheet cushion in that case.

Bottom Line

Albemarle's 186% adjusted EBITDA jump is a lithium price story first, and the company's own Q4 guidance says the sequential tailwind is already fading.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.